AR021094A1 - INHIBITING HETEROCICLICAL COMPOUNDS OF PHOSPHODIESTERASE IV AND ITS USE FOR THE TREATMENT OF INFLAMMATORY DISEASES - Google Patents
INHIBITING HETEROCICLICAL COMPOUNDS OF PHOSPHODIESTERASE IV AND ITS USE FOR THE TREATMENT OF INFLAMMATORY DISEASESInfo
- Publication number
- AR021094A1 AR021094A1 ARP990105594A ARP990105594A AR021094A1 AR 021094 A1 AR021094 A1 AR 021094A1 AR P990105594 A ARP990105594 A AR P990105594A AR P990105594 A ARP990105594 A AR P990105594A AR 021094 A1 AR021094 A1 AR 021094A1
- Authority
- AR
- Argentina
- Prior art keywords
- treatment
- inflammatory diseases
- phosphodiesterase
- inhibiting
- heterociclical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Virology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- AIDS & HIV (AREA)
- Ophthalmology & Optometry (AREA)
- Obesity (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Molecular Biology (AREA)
Abstract
N-oxidos de la formula (1) donde R1 es CH3, CH2F- CHF2 o CF3; R2 es CH3 o CF3; R3 es F, Cl, Br, CN o CH3; y R4 es H, F, Cl, Br, CN o CH3; y salesfarmacéuticamente aceptables de los mismos, son utiles como agentes terapéuticos, por ejemplo para el tratamiento de enfermedades inflamatorias.N-oxides of the formula (1) wherein R1 is CH3, CH2F-CHF2 or CF3; R2 is CH3 or CF3; R3 is F, Cl, Br, CN or CH3; and R4 is H, F, Cl, Br, CN or CH3; and pharmaceutically acceptable salts thereof, are useful as therapeutic agents, for example for the treatment of inflammatory diseases.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9824160.7A GB9824160D0 (en) | 1998-11-04 | 1998-11-04 | Heterocyclic compounds and their therapeutic use |
Publications (1)
Publication Number | Publication Date |
---|---|
AR021094A1 true AR021094A1 (en) | 2002-06-12 |
Family
ID=10841838
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP990105594A AR021094A1 (en) | 1998-11-04 | 1999-11-04 | INHIBITING HETEROCICLICAL COMPOUNDS OF PHOSPHODIESTERASE IV AND ITS USE FOR THE TREATMENT OF INFLAMMATORY DISEASES |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1045845A1 (en) |
JP (1) | JP2002528541A (en) |
KR (1) | KR20010033842A (en) |
CN (1) | CN1287555A (en) |
AR (1) | AR021094A1 (en) |
AU (1) | AU735574B2 (en) |
BR (1) | BR9906719A (en) |
CA (1) | CA2312430A1 (en) |
CO (1) | CO5160316A1 (en) |
GB (1) | GB9824160D0 (en) |
HU (1) | HUP0100570A3 (en) |
IL (1) | IL136398A0 (en) |
NO (1) | NO20003439D0 (en) |
NZ (1) | NZ504933A (en) |
PE (1) | PE20001232A1 (en) |
PL (1) | PL341732A1 (en) |
RU (1) | RU2205830C2 (en) |
SK (1) | SK10082000A3 (en) |
TR (1) | TR200001941T1 (en) |
TW (1) | TW546296B (en) |
WO (1) | WO2000026208A1 (en) |
ZA (1) | ZA200002604B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7217722B2 (en) | 2000-02-01 | 2007-05-15 | Kirin Beer Kabushiki Kaisha | Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same |
DE10318610A1 (en) | 2003-04-24 | 2004-11-11 | Elbion Ag | 7-azaindoles and their use as therapeutic agents |
JP2007505834A (en) * | 2003-09-15 | 2007-03-15 | シェーリング コーポレイション | Synthesis of quinoline 5-carboxamides useful for the preparation of PDEIV inhibitors |
US20070048389A1 (en) * | 2005-08-26 | 2007-03-01 | Fu-Pao Tsao | Stabilized and preserved ketotifen ophthalmic compositions |
AU2006305619A1 (en) | 2005-10-19 | 2007-04-26 | Ranbaxy Laboratories Limited | Pharmaceutical compositions of muscarinic receptor antagonists |
WO2017089347A1 (en) | 2015-11-25 | 2017-06-01 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL126557A (en) * | 1996-05-20 | 2002-09-12 | Darwin Discovery Ltd | Tnf and/or pde-iv inhibiting quinoline (thio) carboxamides and pharmaceutical compositions containing them |
WO1997048697A1 (en) * | 1996-06-19 | 1997-12-24 | Rhone-Poulenc Rorer Limited | Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
-
1998
- 1998-11-04 GB GBGB9824160.7A patent/GB9824160D0/en not_active Ceased
-
1999
- 1999-10-20 TW TW088118098A patent/TW546296B/en not_active IP Right Cessation
- 1999-11-02 EP EP99954132A patent/EP1045845A1/en not_active Withdrawn
- 1999-11-02 CN CN99801954A patent/CN1287555A/en active Pending
- 1999-11-02 WO PCT/GB1999/003628 patent/WO2000026208A1/en not_active Application Discontinuation
- 1999-11-02 TR TR2000/01941T patent/TR200001941T1/en unknown
- 1999-11-02 KR KR1020007007402A patent/KR20010033842A/en not_active Application Discontinuation
- 1999-11-02 PL PL99341732A patent/PL341732A1/en not_active Application Discontinuation
- 1999-11-02 JP JP2000579596A patent/JP2002528541A/en active Pending
- 1999-11-02 IL IL13639899A patent/IL136398A0/en unknown
- 1999-11-02 CA CA002312430A patent/CA2312430A1/en not_active Abandoned
- 1999-11-02 BR BR9906719-6A patent/BR9906719A/en not_active IP Right Cessation
- 1999-11-02 NZ NZ504933A patent/NZ504933A/en unknown
- 1999-11-02 RU RU2000120469/04A patent/RU2205830C2/en not_active IP Right Cessation
- 1999-11-02 HU HU0100570A patent/HUP0100570A3/en unknown
- 1999-11-02 AU AU10571/00A patent/AU735574B2/en not_active Ceased
- 1999-11-02 SK SK1008-2000A patent/SK10082000A3/en unknown
- 1999-11-03 PE PE1999001102A patent/PE20001232A1/en not_active Application Discontinuation
- 1999-11-04 CO CO99069730A patent/CO5160316A1/en unknown
- 1999-11-04 AR ARP990105594A patent/AR021094A1/en not_active Application Discontinuation
-
2000
- 2000-05-25 ZA ZA200002604A patent/ZA200002604B/en unknown
- 2000-07-03 NO NO20003439A patent/NO20003439D0/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2312430A1 (en) | 2000-05-11 |
NZ504933A (en) | 2001-10-26 |
IL136398A0 (en) | 2001-06-14 |
GB9824160D0 (en) | 1998-12-30 |
TW546296B (en) | 2003-08-11 |
KR20010033842A (en) | 2001-04-25 |
SK10082000A3 (en) | 2001-01-18 |
BR9906719A (en) | 2000-10-17 |
NO20003439L (en) | 2000-07-03 |
ZA200002604B (en) | 2001-05-28 |
TR200001941T1 (en) | 2001-01-22 |
PL341732A1 (en) | 2001-05-07 |
RU2205830C2 (en) | 2003-06-10 |
AU1057100A (en) | 2000-05-22 |
JP2002528541A (en) | 2002-09-03 |
HUP0100570A3 (en) | 2002-12-28 |
CN1287555A (en) | 2001-03-14 |
CO5160316A1 (en) | 2002-05-30 |
PE20001232A1 (en) | 2000-11-28 |
HUP0100570A2 (en) | 2001-10-28 |
EP1045845A1 (en) | 2000-10-25 |
AU735574B2 (en) | 2001-07-12 |
WO2000026208A1 (en) | 2000-05-11 |
NO20003439D0 (en) | 2000-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR023727A1 (en) | COMPOUNDS USED IN THE TREATMENT OF INFLAMMATORY MATTERS | |
SV1999000009A (en) | DERIVATIVES OF 2- (PURIN-9-IL) -TETRAHIDROFURAN-3,4-DIOL REF. PG3388 / SV | |
YU128091A (en) | DERIVATI HINUKLIDINA | |
SV1999000016A (en) | DERIVATIVES OF 2- (PURIN-9-IL-TETRAHIDROFURAN-3,4-DIOL REF. PG3443 / SV | |
ATE249214T1 (en) | PENTAFLUOROBENZENESULFONAMIDES AND ANALOGUES | |
ATE264846T1 (en) | SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AND THEIR USE FOR TREATING RETROVIRAL INFECTIONS | |
TR199901905T2 (en) | 2- (P�rin-9-yl) -tetrahidrofuran-3,4-diol t�revleri. | |
UY28150A1 (en) | THERAPEUTIC AGENTS | |
ATE302775T1 (en) | CARBOLINE DERIVATIVES | |
PT896533E (en) | PENTAFLUOROBENZENOSULFONAMIDAS AND ANALOGOS | |
AR007828A1 (en) | COMPOUNDS DERIVED FROM PIRIDILPIRROL, PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
PT1159279E (en) | 4-OXO-4,7-DIHYDROTIENE-2,3-B | PYRIDINE-5-CARBOXAMIDES AS ANTIVIRAL AGENTS | |
SE9702564D0 (en) | New compounds | |
ATE346067T1 (en) | CARBOLINE DERIVATIVES | |
DE60121461D1 (en) | CONDENSED PYRIDOINDOL DERIVATIVES | |
ES2101858T3 (en) | GENESERINE DERIVATIVES AS CHOLINESTERASE INHIBITORS. | |
AR018162A1 (en) | SUBSTITUTED PIRROLS, PHARMACEUTICAL COMPOSITION AND THE USE OF THEM FOR THE PREPARATION OF SUCH PHARMACEUTICAL COMPOSITION | |
AR007108A1 (en) | ANTI-TUMOR AND ANTIVIRAL RENTAL AGENTS, PROCEDURE FOR THEIR PREPARATION, USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION CONTAINING SUCH AGENTS. | |
SE9702563D0 (en) | Compounds | |
DE60112960D1 (en) | CONDENSED PYRIDOINDOL DERIVATIVES | |
ES2111352T3 (en) | USE OF DIESTER PHOSPHATE FOR THE TREATMENT OF RETINAL DISEASES. | |
ECSP044971A (en) | ISOXAZOLOPIRIDINONAS AND ITS USE IN PARKINSON'S DISEASE TREATMENT | |
AR021094A1 (en) | INHIBITING HETEROCICLICAL COMPOUNDS OF PHOSPHODIESTERASE IV AND ITS USE FOR THE TREATMENT OF INFLAMMATORY DISEASES | |
ES2082894T3 (en) | DIHYDROPIRIDE (4,3-D) PIRIMIDINES 4-SUBSTITUTED AS ANALGESICS AND TOPIC ANTI-INFLAMMATORY AGENTS FOR THE TREATMENT OF SKIN DISEASES. | |
ATE330958T1 (en) | PYRAZINO 1'2':1,6ÖPYRIDO 3,4-BÖINDOL DERIVATIVES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |